Transcription factors as targets for cancer therapy

被引：940
|
作者：
Darnell, JE [1 ]
机构：
[1] Rockefeller Univ, Lab Mol Cell Biol, New York, NY 10021 USA
来源：
NATURE REVIEWS CANCER | 2002年 / 2卷 / 10期
关键词：
D O I：
10.1038/nrc906
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs. That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signalling pathways than there are oncogenic transcription factors. But how could specific transcription-factor activity be inhibited?.
引用
收藏
页码：740 / 749
页数：10
相关论文
共 50 条
  • [21] Transcription factors: their potential as targets for an individualized therapeutic approach to cancer
    Mees, C.
    Nemunaitis, J.
    Senzer, N.
    CANCER GENE THERAPY, 2009, 16 (02) : 103 - 112
  • [22] FOXO transcription factors in cancer development and therapy
    de Brachene, Alexandra Coomans
    Demoulin, Jean-Baptiste
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (06) : 1159 - 1172
  • [23] Targeting transcription factors for prevention and therapy of cancer
    不详
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 : 4 - 5
  • [24] FOXO transcription factors in cancer development and therapy
    Alexandra Coomans de Brachène
    Jean-Baptiste Demoulin
    Cellular and Molecular Life Sciences, 2016, 73 : 1159 - 1172
  • [25] Targeting oncogenic transcription factors for cancer therapy
    Gautam SETHI
    中国药理学与毒理学杂志, 2018, 32 (04) : 250 - 250
  • [26] Targeting transcription factors for cancer gene therapy
    Libermann, TA
    Zerbini, LF
    CURRENT GENE THERAPY, 2006, 6 (01) : 17 - 33
  • [27] Neogenes induced by oncogenic chimeric transcription factors as potential targets for therapy
    Petit, Floriane
    Lalanne, Ana
    Collin, Celine
    Waterfall, Joshua
    Lantz, Olivier
    Delattre, Olivier
    CANCER RESEARCH, 2024, 84 (17)
  • [28] Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
    Xie, Kangzhe
    Tan, Keely
    Naylor, Matthew J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review
    Uebelhoer, Melanie
    Lambert, Cecile
    Grisart, Juliane
    Guse, Kilian
    Plutizki, Stanislav
    Henrotin, Yves
    FRONTIERS IN MEDICINE, 2023, 10
  • [30] Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
    Yang, Jer-Yen
    Hung, Mien-Chie
    CURRENT DRUG TARGETS, 2011, 12 (09) : 1284 - 1290
12345